-
1321
Current status of cytokine-induced killer cells and combination regimens in breast cancer
Published 2025-02-01“…This review outlines the current status of cytokine-induced killer cell therapies and their combination strategies, especially the combination of chemotherapy with molecularly targeted treatments, for the management of breast cancer.…”
Get full text
Article -
1322
Distinguishing between HPV-Associated Metastatic Anal Squamous Cell Cancer and HPV-Associated Oropharyngeal Cancer
Published 2020-01-01“…A patient with a history of locally advanced ASCC treated with standard concurrent radiation therapy and chemotherapy in 2015 is described. In 2018, an enlarged supraclavicular lymph node was excised demonstrating squamous cell carcinoma and radiographic staging revealed no other areas suspicious for malignancy. …”
Get full text
Article -
1323
Salvage Therapy for Refractory Aids-Related Primary Central Nervous System Lymphoma
Published 2012-01-01“…After two cycles of high-dose metotrexate (HD-MTX-)-based chemotherapy, the tumor progressed. He underwent whole brain radiotherapy achieving complete response. …”
Get full text
Article -
1324
Primary Orbital Mesenchymal Chondrosarcoma: Case Report and Review of the Literature
Published 2012-01-01“…Complete removal of the tumor is the mainstay of treatment, but adjuvant radiation therapy and chemotherapy should be considered.…”
Get full text
Article -
1325
A case report of a primary lymphoma of the tongue presenting as trigeminal neuralgia
Published 2019-08-01“…The patient underwent standard chemotherapy with complete radiological response, but minimal recovery of the affected neurological functions. …”
Get full text
Article -
1326
Gastroesophageal junction adenocarcinoma. A case report
Published 2010-12-01“…The patient underwent surgery and chemotherapy and has had a favourable outcome up until today. …”
Get full text
Article -
1327
Determination of butyric acid dosage based on clinical and experimental studies – a literature review
Published 2020-06-01“…Butyric acid is used for the treatment and prevention of exacerbations of various gastrointestinal diseases: diarrhoea, intestinal inflammations, functional disorders, dysbiosis, and post-surgery or post-chemotherapy conditions. The current standard doses of butyric acid (150–300 mg) range between 1.5–3% and 15–30% of the reported daily demand. …”
Get full text
Article -
1328
Systemic Capillary Leak Syndrome as an Initial Presentation of ALK-Negative Anaplastic Large Cell Lymphoma
Published 2012-01-01“…The SCLS resolved with treatment of the malignancy with steroids and chemotherapy.…”
Get full text
Article -
1329
Enucleation for retinoblastoma in a 22-month-old boy
Published 2023-07-01“…After enucleation, he was referred to the oncologist for adjuvant chemotherapy. Early retinoblastoma detection is crucial in increasing the cure rate while maintaining children's vision.…”
Get full text
Article -
1330
Treatment of Bleeding Diathesis Associated with a Heparin-Like Anticoagulant in Plasma Cell Neoplasia Using Protamine
Published 2018-01-01“…We postulate that chemotherapy, targeted therapies, and immunotherapies may also disrupt production of a HLAC. …”
Get full text
Article -
1331
Renal immature teratoma in infant: A rare case report
Published 2025-03-01“…Surgical removal is the primary treatment, with chemotherapy for recurrence if necessary.…”
Get full text
Article -
1332
CML Developing Three Years after Therapy Completion in a Child with Ph(−) Pre-B-ALL
Published 2011-01-01“…The upcoming question in this case scenario is whether developed CML is a secondary leukemia due to previous ALL chemotherapy or just a relapse case of primary leukemia.…”
Get full text
Article -
1333
Towards Point-of-Care Diagnostic and Staging Tools for Human African Trypanosomiaisis
Published 2012-01-01“…Control of this disease almost exclusively relies on chemotherapy that should be driven by accurate diagnosis, given the unacceptable toxicity of the few available drugs. …”
Get full text
Article -
1334
Conjunctival Metastasis as an Initial Sign of Small Cell Lung Cancer
Published 2014-01-01“…The primary and metastatic tumors were treated with chemotherapy. Conclusion. Conjunctival metastasis may be the initial manifestation of lung cancer. …”
Get full text
Article -
1335
AXL inhibition in treatment-resistant metastatic adenoid cystic carcinoma
Published 2024-06-01“…Several studies demonstrate that AXL inhibition suppresses tumor cell proliferation, migration, and invasion, sensitizing ACC cells to chemotherapy and radiation therapy. Furthermore, AXL-targeted therapies modulate the tumor microenvironment, disrupting pro-tumorigenic signals. …”
Get full text
Article -
1336
Ewing Sarcoma of Neck - A Rare Case Report
Published 2025-02-01“…Treatment involved neoadjuvant chemotherapy, followed by surgical resection with clear margins, and the patient is currently being monitored for recurrence with a guarded prognosis. …”
Get full text
Article -
1337
Durable disease regression with copanlisib treatment in PI3K-mutated metastasizing ameloblastoma: A case report
Published 2025-12-01“…Initial treatments, including carboplatin, etoposide, and taxane-based chemotherapy, were ineffective. Molecular profiling revealed mutations including PIK3CA H1047R and BRAF V600E. …”
Get full text
Article -
1338
A Case Report of Melanoma as Acute Mastoiditis in a 10-Month-Old Female Child
Published 2019-01-01“…She was diagnosed with a melanoma at the age of 25, for which she was treated with chemotherapy. During her pregnancy, she presented with a recurrence of the disease and died 3 months after delivery. …”
Get full text
Article -
1339
Lymphoepithelioma-Like Carcinoma of the Lung: An Unusual Case and Literature Review
Published 2013-01-01“…He was successfully treated with lobectomy with postoperative adjuvant chemotherapy and is alive without signs of recurrence for 36 months after the diagnosis. …”
Get full text
Article -
1340
Age-Adjusted Schedules of Venetoclax and Hypomethylating Agents to Treat Extremely Elderly Patients with Acute Myeloid Leukemia
Published 2022-01-01“…Recently, the United States FDA has approved venetoclax, a selective oral BCL-2 inhibitor, for use in conjunction with hypomethylating agents (azacitidine or decitabine) or low-dose cytarabine as a first-line treatment option for those AML patients ineligible for standard induction chemotherapy. However, there are nuances and challenges when using this regimen in the extremely elderly AML patients. …”
Get full text
Article